< Back

Open-Label Uncontrolled Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Activity of Nipocalimab in Children Aged 2 to less than 18 years with Generalized Myasthenia Gravis Open


8 to

Study Details
Internal Title: 80202135MYG2001

PCH IRB Number: IRB-22-208
Clinical Trials Government Identifier: NCT05265273

Diagnoses & Treatments: Myasthenia Gravis

Study Type: Clinical Trial

Eligibility: 8 to <18 years of age (for Unites Stated (US) sites only), Diagnosis of myasthenia gravis (MG) with generalized muscle weakness meeting the clinical criteria for generalized myasthenia gravis (gMG) as defined by the Myasthenia Gravis Foundation of America

Enrollment Status: Open

Phase: Other


Coordinator Contact: CRYSTAL ALVAREZ DURAN
Contact Email:


Principal Investigator

Principal Investigator Photo
Medical Director, Neuromuscular Program